Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer

NCT01836679 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small-cell Lung Cancer

Interventions

DRUG: Chidamide
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Placebo

Sponsor

Chipscreen Biosciences, Ltd.